CompletedPhase 2

Percutaneous Treatment of Carpal Tunnel Syndrome With Scan

France40 participantsStarted 2012-01

Plain-language summary

The objective of the study is to evaluate in patients suffering from carpal tunnel syndrome resistant to medical treatment, clinical course after percutaneous treatment under ultrasound guidance. 40 patients will be included in the study. The following parameters will be evaluated: patient satisfaction, pain, functional disability, quality of life and time to return to work. The medico-economic aspect will be analyzed.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient older than 18 years who signed the informed consent. * Patient with an Carpal Tunnel Syndrome Exclusion Criteria: * patient has already undergone surgery of Carpal Tunnel Syndrome * Patient with contra-indications to anesthesia (heart failure, kidney, liver). * Pregnant women * alcoholics in weaning period * Patient whose consent is altered or unable to get a safety procedure * Patient with contra-indication to lidocaine * Patient with contra-indication for the realization of ultrasound endoscopy (carpal tunnel syndrome secondary or anastomosis between the median and ulnar nerves: anastomosis Berritini)

What they're measuring

Pain (visual analogic scale)

Timeframe: change between baseline and day 90 after surgery

paresthesia

Timeframe: change between baseline and day 90 after surgery

muscle strength (dynamometer JAMARD)

Timeframe: change between baseline and day 90 after surgery

Trial details

NCT IDNCT02514317

SponsorUniversity Hospital, Caen

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2013-03

View on ClinicalTrials.gov More Carpal Tunnel Syndrome trials